1. Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD
- Author
-
M. John Gill, Michael J. Silverberg, Sally B. Coburn, Charles S. Rabkin, Kathleen M. Akgün, Thibaut Davy-Mendez, Ank E. Nijhawan, Michael A. Horberg, Kathleen A. McGinnis, Gregory D. Kirk, Yuhang Qian, Angel M. Mayor, Kelly A. Gebo, Edward R. Cachay, Jeffrey M. Jacobson, Jonathan Colasanti, Keri N. Althoff, and Richard D. Moore
- Subjects
Adult ,Acquired Immunodeficiency Syndrome ,Aging ,Index (economics) ,business.industry ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,Article ,Cohort Studies ,Hospitalization ,Infectious Diseases ,medicine ,Humans ,Pharmacology (medical) ,Association (psychology) ,business ,Veterans ,Demography - Abstract
BACKGROUND: People with HIV (PWH) have a higher hospitalization rate than the general population. The Veterans Aging Cohort Study (VACS) Index at study entry well predicts hospitalization in PWH, but it is unknown if the time-updated parameter improves hospitalization prediction. We assessed the association of parameterizations of the VACS Index 2.0 with the 5-year risk of hospitalization. SETTING: PWH ≥ 30 years old with at least 12 months of antiretroviral therapy (ART) use, and contributing hospitalization data from 2000 to 2016 in North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) were included. Three parameterizations of the VACS Index 2.0 were assessed and categorized by quartile: 1) “baseline” measurement at study entry, 2) time-updated measurements, and 3) cumulative scores calculated using the trapezoidal rule. METHODS: Discrete-time proportional hazard models estimated the crude and adjusted associations (and 95% confidence intervals [CI]) of the VACS Index parameterizations and all-cause hospitalizations. The Akaike information criterion (AIC) assessed the model fit with each of the VACS Index parameters. RESULTS: Among 7,289 patients, 1,537 were hospitalized. Time-updated VACS Index fitted hospitalization best with a more distinct dose-response relationship (score
- Published
- 2022